Optimise your vaccine R&D pipeline to deliver business growth
Your opportunity to learn from the innovators driving the growth and investment in the vaccine market to help generate new revenue streamsVaccines are breaking new ground, delivering potential new revenue streams to the pharmaceutical industry. Regardless of whether you`re an experienced developer or a newcomer to this growing field, there`s plenty to get excited about.
Expectations are building in the community too and if you`re serious about capitalising on Vaccines, there`s only one place to be in February. Designed by industry leaders at
Merck & Co, Novartis, sanofi pasteur, Medimmune, Pevion, FDA, Intercell and many others, the event focuses on overcoming the challenges faced in driving development and innovation of vaccines into the clinic and to market.
Why attend?Meet
industry leaders and vaccine experts from big pharma and large biotech, and understand how they are using innovative new technologies and approaches to accelerate progress in vaccines innovation.
Leave the meeting with a
surplus of new ideas and contacts to take back to your organisation.
The Biorbis
Vaccine Innovation 2011 meeting focuses on
delivering practical value, pushing existing boundaries in the vaccine sector and helping to grow your business and generate new revenue streams.
BackgroundDwindling pipelines and the lack of blockbuster drugs has made the importance of new innovative products more vital than ever. Innovative new vaccines and related technologies offer a fantastic opportunity to bolster pipelines and deliver improved vaccine development to your company.
The Biorbis Vaccine Innovation 2011 meeting will bring together the industry experts to debate where breakthroughs will be made and discuss how vaccines can deliver new opportunities.
Covering everything from regulation to clinical case studies, you`ll find all you need to know about vaccine innovation. No matter what stage you`re at, learning how to excel in this rapidly expanding field is critical to remain competitive in the vaccine industry.
By attending this event you will: - Hear from the FDA on the best approaches to keep up to date with the rapidly changing global regulatory landscape that`s making vaccine development more challenging
- Experience is key, especially in such a competitive market. Take this opportunity to understand the lessons learned from sanofi pasteur on developing their vaccines R&D pipeline
- Partnering is very much at the forefront of vaccine pipeline development. Understand Intercell`s approach to biotech partnering strategies to make vaccines globally available
- Debate with Pevion Biotech the advantages and challenges in development and manufacturing of VLP-based vaccines and how you could utilise this technology in your developments
- Hear how Transgene are developing Viral based therapeutic vaccines and their synergy with other cancer vaccines
- Learn from Merck & Co the future trends in pneumococcal vaccine research and how this could be a possibility for your pipeline development
- Understand the mechanism of action of vaccine adjuvants Alum and MF59 with Novartis Research Centre
- Discuss new technologies for improved vaccines with representatives from Novartis Research and Diagnostics, Okairos, Trinity College Dublin, Baxter and Inviragen
